Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants.
Clinical trial NCT07035990 · RECRUITING
Trial details
- NCT number
- NCT07035990
- Sponsor
- Sionna Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-23
- Primary completion
- 2026-06-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.